Loading...
Loading...
Among the 7 tracked institutional investors we monitor, RPRX (ROYALTY PHARMA PLC) is held with a combined value of $3.56B across 76,204,874 shares. The largest holder is BlackRock, Inc. with a position worth $1.24B (0.02% of their portfolio). 2 funds opened new positions in the most recent quarter. 1 fund increased its holdings. 4 funds reduced their position.
Total Institutional Value
$3.56B
Total Shares Held
76,204,874
Institutional Holders
7
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $1.24B | 0.02% | -1.1% |
| 2 | FMR LLC | $1.21B | 0.06% | -4.3% |
| 3 | STATE STREET CORP | $527.18M | 0.02% | +3.2% |
| 4 | VANGUARD GROUP INC | $383.87M | 0.01% | New |
| 5 | CITADEL ADVISORS LLC | $141.01M | 0.02% | -45.2% |
| 6 | RENAISSANCE TECHNOLOGIES LLC | $37.94M | 0.06% | New |
| 7 | Point72 Asset Management, L.P. | $23.51M | 0.03% | -8.3% |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of RPRX with a position worth $1.24B, representing 0.02% of their portfolio. In total, 7 institutional investors hold RPRX with a combined value of $3.56B.
In the most recent quarter, 2 funds opened a new position in RPRX. Additionally, 1 increased their holdings and 4 reduced their positions.
Institutional investors hold $3.56B worth of RPRX stock across 7 positions. The largest institutional holder is BlackRock, Inc. with $1.24B in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For RPRX, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their RPRX positions.